Outlook Therapeutics- Warrants Inventory

As of the most recent data (March 2026), OTLKW shows a inventory of $3.3T. That compares with $3.6T in the prior-year period — down 7.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, OTLKW's inventory is now $3.3T (was $3.6T) — a 7.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Outlook Therapeutics- Warrants is outperforming or lagging.

Tracking OTLKW's inventory over time shows whether Outlook Therapeutics- Warrants is scaling, shrinking, or reshaping that part of the business. The current reading is $3.3T That compares with $3.6T in the prior-year period — down 7.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this inventory page, Stockcircle has Outlook Therapeutics- Warrants's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $3.3T) with ownership activity and broader fundamentals.

Outlook Therapeutics- Warrants's inventory is $3.3T; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.